Jørn Frederik Falch
Directeur/Membre du Conseil chez NeuronIcon ApS
Profil
Dr. Jørn F.
Falch, MD MBA, is an Investment Manager at Capnova A/S, Project Manager at Oestjysk Innovation A/S, and Chairman at EnFutech ApS.
He is on the Board of Directors at Curatio ApS, NeuronIcon ApS, SKAU ApS, Pirutech ApS, Pleuratech ApS, Health Equipment Denmark ApS, Como Biotech ApS, and IOL Innovations ApS.
Dr. Falch was previously employed as an Investment Manager by Østjysk Innovation A.
He also served on the board at AtheroCheck ApS, Cytoguide ApS, and FCMB ApS.
Postes actifs de Jørn Frederik Falch
| Sociétés | Poste | Début |
|---|---|---|
| Oestjysk Innovation A/S | Corporate Officer/Principal | 07/07/2009 |
Curatio ApS
 Curatio ApS Medical SpecialtiesHealth Technology Curatio ApS develops devices for mechanical cleaning of wounds in emergency rooms. Its products are marketed under the brand names Curapulse, Curasafe, and Curagate. The company is headquartered in Nordborg, Denmark. | Directeur/Membre du Conseil | 26/08/2011 |
NeuronIcon ApS
 NeuronIcon ApS BiotechnologyHealth Technology Part of Lundbeck Foundation, NeuronIcon ApS is a biotechnology manufacturing Danish company. The company is based in Aarhus, Denmark. NeuronIcon was acquired by H. Lundbeck A/S on July 07, 2009. | Directeur/Membre du Conseil | 26/08/2011 |
Health Equipment Denmark ApS
 Health Equipment Denmark ApS Medical DistributorsDistribution Services Health Equipment Denmark ApS creates products for the fixation of medical tubes. It manufactures applications with the purpose of facilitating work processes for health staff and improving the comfort of patients when hospitalized. Its product, HEDclip, is used to fixate dialysis tubes. The company was founded by Kristian Rye Veedfald and Mads Hemdorff Petersen in 2003 and is headquartered in Aarhus, Denmark. | Directeur/Membre du Conseil | - |
IOL Innovations ApS
 IOL Innovations ApS Packaged SoftwareTechnology Services IOL Innovations ApS develops software to improve vision through the lens surgery. It produces the PhacoOptics software for cataract surgery, clear lens surgery, refractive lens exchange, and other surgical procedures on the eye lens. The firm evaluates and treats patients with ocular lens surgery with implantation of an artificial intraocular lens. The company was founded on January 26, 2009 and is headquartered in Aarhus, Denmark. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jørn Frederik Falch
| Sociétés | Poste | Fin |
|---|---|---|
Capnova A/S
 Capnova A/S Investment ManagersFinance Capnova A/S (Capnova) is an independent venture capital firm headquartered in Aarhus, Denmark. The firm was established in 1990, and is owned by a group of institutional investors with support from the Government of Denmark. | Private Equity Investor | 28/02/2015 |
iSD Immunotech ApS
 iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Directeur/Membre du Conseil | 09/02/2015 |
Cytoguide ApS
 Cytoguide ApS Pharmaceuticals: MajorHealth Technology Cytoguide is a new biotech company devoted to the development of combined drugs that target receptors on cells in pathological tissues for medical purposes by linking drug candidates and registered drugs with known pharmacological effects to targeting receptor-binding protein partners. The development of receptor-targeted therapeutics will focus on the macrophage specific receptor CD163, the most abundant transport receptor on macrophages. The company has the IP right for existing CD163 targeting technology as well as strong scientific experience and know-how to exploit the use of this receptor for drug therapy. The combined drugs are aimed to improve the treatment of monocyte/macrophage-related diseases including autoimmune disease, leukemia and infectious diseases. | Directeur/Membre du Conseil | 20/05/2014 |
AtheroCheck ApS
 AtheroCheck ApS Miscellaneous Commercial ServicesCommercial Services Atherocheck ApS is a holding company that provides atherosclerosis research services. It designs and develops diagnostic test for the early diagnosis of patients at risk of developing atherosclerosis. The firm is categorized under other research and experimental development on natural sciences and engineering. The company was founded in 2006 and is headquartered in Aarhus, Denmark. | Directeur/Membre du Conseil | 21/04/2014 |
| ░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
FCMB ApS
 FCMB ApS Miscellaneous Commercial ServicesCommercial Services FCMB, based in Vejle, Denmark, is a molecular diagnostics company that develops a system for prenatal genetic analysis. FCMB is committed to developing new, no risk diagnostic method to assess genetic abnormalities, such as Down syndrome. Their team includes world-class scientists within the field of fetal cell research and experts in prenatal testing. | Commercial Services |
| Oestjysk Innovation A/S | |
Cytoguide ApS
Cytoguide ApS Pharmaceuticals: MajorHealth Technology Cytoguide is a new biotech company devoted to the development of combined drugs that target receptors on cells in pathological tissues for medical purposes by linking drug candidates and registered drugs with known pharmacological effects to targeting receptor-binding protein partners. The development of receptor-targeted therapeutics will focus on the macrophage specific receptor CD163, the most abundant transport receptor on macrophages. The company has the IP right for existing CD163 targeting technology as well as strong scientific experience and know-how to exploit the use of this receptor for drug therapy. The combined drugs are aimed to improve the treatment of monocyte/macrophage-related diseases including autoimmune disease, leukemia and infectious diseases. | Health Technology |
AtheroCheck ApS
AtheroCheck ApS Miscellaneous Commercial ServicesCommercial Services Atherocheck ApS is a holding company that provides atherosclerosis research services. It designs and develops diagnostic test for the early diagnosis of patients at risk of developing atherosclerosis. The firm is categorized under other research and experimental development on natural sciences and engineering. The company was founded in 2006 and is headquartered in Aarhus, Denmark. | Commercial Services |
Curatio ApS
Curatio ApS Medical SpecialtiesHealth Technology Curatio ApS develops devices for mechanical cleaning of wounds in emergency rooms. Its products are marketed under the brand names Curapulse, Curasafe, and Curagate. The company is headquartered in Nordborg, Denmark. | Health Technology |
NeuronIcon ApS
NeuronIcon ApS BiotechnologyHealth Technology Part of Lundbeck Foundation, NeuronIcon ApS is a biotechnology manufacturing Danish company. The company is based in Aarhus, Denmark. NeuronIcon was acquired by H. Lundbeck A/S on July 07, 2009. | Health Technology |
Østjysk Innovation A/S
 Østjysk Innovation A/S Investment ManagersFinance Østjysk Innovation A/S provides knowledge, skills, and administrative services. It also provides services in Biotechnology, medical technology and electronics. The company is headquartered in Aarhus, Denmark. | Finance |
EnFutech ApS
 EnFutech ApS BiotechnologyHealth Technology EnFutech ApS is a holding company that develops technologies for prevention, treatment, and eradication of Human Immunodeficiency Virus (HIV). Its platforms include both a new type of inhibitor that can be used as a prophylactic agent as well as a traditional drug for treatment of infection and a gene therapeutical approach to rendering the T-cells immune to HIV infection. The firm aims to combat infection, by developing effective anti-HIV treatments that can remove the virus both before and after it infects human cells. Its treatment is based on its novel technologies of blocking the HIV co-receptors using retargeted envelope proteins and receptor interference. The company was founded by Finn Skou Pedersen and Martin Tolstrup on August 23, 2007 and is headquartered in Aarhus, Denmark. | Health Technology |
iSD Immunotech ApS
iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Health Technology |
Pirutech ApS
 Pirutech ApS Pharmaceuticals: MajorHealth Technology Pirutech ApS develops device for removing pills from blister packs. The firm product is PiruCare that allows dispensing the pills from blister packs. The company was founded on July 27, 2006 and is headquartered in Frederiksberg, Denmark. | Health Technology |
Pleuratech ApS
 Pleuratech ApS Medical SpecialtiesHealth Technology Pleuratech ApS develops an instrument for insertion of chest tubes into the thoracic cavity for the treatment of pleural effusion. It provides thoracic surgeons with a tool that helps them place chest drains. The company's Pleuratech KatGuide a tool that promotes proper insertion and placement of large bore chest drains and curved shape of the KatGuide tube helps the surgeon to bring the drain to any area of the pleural cavity without damaging the lung. Pleuratech was founded by Niels Katballe and Peter Heydorn Kristensen on May 7, 2010 and is headquartered in Aarhus, Denmark. | Health Technology |
Health Equipment Denmark ApS
Health Equipment Denmark ApS Medical DistributorsDistribution Services Health Equipment Denmark ApS creates products for the fixation of medical tubes. It manufactures applications with the purpose of facilitating work processes for health staff and improving the comfort of patients when hospitalized. Its product, HEDclip, is used to fixate dialysis tubes. The company was founded by Kristian Rye Veedfald and Mads Hemdorff Petersen in 2003 and is headquartered in Aarhus, Denmark. | Distribution Services |
Como Biotech ApS
 Como Biotech ApS BiotechnologyHealth Technology Como Biotech ApS is provides research and experimental development in biotechnology. It works with proteins for diagnostic and therapeutic purposes. The firm is categorized under Commercial Physical and Biological Research. The company was founded by Claus Oxvig and Michael Toft Overgaard in 2000 and is headquartered in Aarhus, Denmark. | Health Technology |
Capnova A/S
Capnova A/S Investment ManagersFinance Capnova A/S (Capnova) is an independent venture capital firm headquartered in Aarhus, Denmark. The firm was established in 1990, and is owned by a group of institutional investors with support from the Government of Denmark. | Finance |
IOL Innovations ApS
IOL Innovations ApS Packaged SoftwareTechnology Services IOL Innovations ApS develops software to improve vision through the lens surgery. It produces the PhacoOptics software for cataract surgery, clear lens surgery, refractive lens exchange, and other surgical procedures on the eye lens. The firm evaluates and treats patients with ocular lens surgery with implantation of an artificial intraocular lens. The company was founded on January 26, 2009 and is headquartered in Aarhus, Denmark. | Technology Services |
